Respiri Limited
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RSHUF research report →
Companyrespiri.co
Respiri Limited, an e-health SaaS company, researches, develops, and commercializes medical devices in Australia. The company develops, produces, and sells mobile health applications. Its products include wheezo, an electronic wheeze detection tool to detect wheeze in children; respiri mobile application; and Respiri health portal.
- CEO
- Marjan Mikel
- IPO
- 2011
- HQ
- Melbourne, VIC, AU
Price Chart
Valuation
- Market Cap
- $91.52M
- P/E
- -4.71
- P/S
- 113.77
- P/B
- 12.74
- EV/EBITDA
- -7.50
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 99.16%
- Op Margin
- -1673.36%
- Net Margin
- -1560.30%
- ROE
- -411.64%
- ROIC
- -191.13%
Growth & Income
- Revenue
- $456.91K · 547.80%
- Net Income
- $-7,129,247 · -23.44%
- EPS
- $-0.01 · 2.78%
- Op Income
- $-7,645,835
- FCF YoY
- -47.19%
Performance & Tape
- 52W High
- $0.06
- 52W Low
- $0.00
- 50D MA
- $0.06
- 200D MA
- $0.04
- Beta
- -0.44
- Avg Volume
- 3.22K
Get TickerSpark's AI analysis on RSHUF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our RSHUF Coverage
We haven't published any research on RSHUF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate RSHUF Report →